Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Shares Shorted: Short Interest Down 66.5% in September

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 10,416 shares, a decrease of 66.5% from the August 31st total of 31,081 shares. Based on an average daily volume of 6,751 shares, the days-to-cover ratio is presently 1.5 days.

Fisher & Paykel Healthcare Stock Performance

Shares of FSPKF remained flat at $25.60 during midday trading on Friday. 2 shares of the stock traded hands, compared to its average volume of 3,395. The firm has a 50 day moving average price of $24.74 and a 200 day moving average price of $23.19. Fisher & Paykel Healthcare has a one year low of $19.01 and a one year high of $26.53.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Royal Bank Of Canada upgraded shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a report on Tuesday, September 15th. Citigroup upgraded shares of Fisher & Paykel Healthcare to a “buy” rating in a research note on Thursday, September 10th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy”.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s offerings are designed for use in hospitals, intensive care units, operating rooms and homes.

Its product portfolio includes respiratory humidification systems, nasal high-flow therapy systems, noninvasive ventilation equipment, continuous positive airway pressure (CPAP) and bilevel masks, neonatal respiratory care products, and related consumables and accessories.